Genprex, Inc. cotiza a 2.69 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic,…
| Periodo | 2025-05 | 2025-04 | 2024-11 | 2024-08 |
|---|---|---|---|---|
| Real | $-286.00 | $2.58 | $-1353.00 | $-3300.00 |
| Estimado | $-451.00 | $-0.39 | $-3003.00 | $-2530.00 |
| Sorpresa | +36.6% | +761.5% | +54.9% | -30.4% |
| Métrica | GNPX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -203.8% | -40.4% | -163.4% |
| ROA | -159.8% | -32.0% | -127.7% |
| Current Ratio | 3.84 | 2.84 | +1.00 |
| Debt / Equity | — | 0.28 | — |